Docs Who Lift
by Docs Who Lift
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 17 chart positions in 17 markets.
By chart position
- 🇺🇸US · Medicine#7230K to 100K
- 🇦🇺AU · Medicine#1595K to 30K
- 🇬🇧GB · Medicine#1615K to 30K
- 🇳🇱NL · Medicine#2930K to 100K
- 🇸🇪SE · Medicine#1181K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
58K to 208K🎙 ~2x weekly·149 episodes·Last published 3d ago - Monthly Reach
Unique listeners across all episodes (30 days)
116K to 415K🇺🇸24%🇳🇱24%🇦🇺7%+14 more - Active Followers
Loyal subscribers who consistently listen
35K to 125K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 16 epsHosts
Recent guests
Recent episodes
Does Metabolically Healthy Obesity Even Exist?
Aug 30, 2026
Unknown duration
Is Your Obesity Genetic? Food Noise and Bardet-Biedl Syndrome Explained
Aug 3, 2026
Unknown duration
PCOS Renamed to PMOS? Here's Why and What Changes for You
Jul 7, 2026
36m 52s
Are Peptides the New Snake Oil? What the Actual Science Says With Barbell Medicine
Jun 17, 2026
57m 24s
Retatrutide Phase 3 Results: What the Data Actually Means
Jun 8, 2026
45m 03s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 8/30/26 | Does Metabolically Healthy Obesity Even Exist? | Dr. Christian Rodriguez unpacks his review on metabolically healthy obesity, showing why the concept is mostly a temporary phase rather than a stable protective state. He and the hosts compare the new Lancet Commission obesity criteria against the ACE staging system, then debate GLP-1 stigma and the ethics of treating obesity before it turns severe. | — | ||||||
| 8/3/26 | Is Your Obesity Genetic? Food Noise and Bardet-Biedl Syndrome Explained | Is severe, insatiable hunger a failure of willpower or hardcoded into your biology? In this episode of Docs Who Lift, Dr. Spencer and Dr. Karl Nadolsky speak with obesity specialist Dr. Jesse Richards to uncover Bardet-Biedl Syndrome (BBS), the updated 2024 diagnostic criteria, and how targeted therapies offer hope when standard GLP-1s and willpower aren't enough. | — | ||||||
| 7/7/26 | women's healthPCOS+3 | Dr. Susan Brian | polycystic ovarian syndromeanovulatory androgen excess | — | PCOSPMOS+6 | — | 36m 52s | ||
| 6/17/26 | peptideshealth+4 | Dr. Austin BarakiDr. Jordan Feigenbaum | Barbell Medicine | — | peptidesrandomized controlled trials+5 | — | 57m 24s | ||
| 6/8/26 | weight lossdiabetes+4 | David W | retatrutidetirzepatide+2 | — | retatrutideweight loss+6 | — | 45m 03s | ||
| 5/25/26 | GLP-1 medicationsweight loss+3 | Dr. Spencer Nadolsky | tirzepatideorforglipron | — | GLP-1tirzepatide+5 | — | 39m 46s | ||
| 5/18/26 | GLP-1 medicinesbone health+4 | Dr. Susan Brian | YaleGLP-1 | — | GLP-1bone loss+5 | — | 31m 42s | ||
| 5/5/26 | heavy metal toxicityinfluencer scams+4 | Dr. Eryn Russo | heavy metal detox industrylead+2 | — | heavy metal toxicitydetox scams+4 | — | 52m 36s | ||
| 4/21/26 | geneticsweight loss+4 | Dr. Adam Auton | 23andMe | — | GLP-1genetics+5 | — | 24m 36s | ||
| 4/14/26 | GLP-1 medicinesmuscle loss+5 | Dr. Henning Langer | GLP-1 medicinessemaglutide+1 | — | GLP-1muscle loss+6 | — | 36m 25s | ||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 4/2/26 | resistance trainingmuscle building+4 | Dr. Stuart Phillips | American College of Sports Medicine | — | weight liftingresistance training+6 | — | 51m 56s | ||
| 3/23/26 | weight lossclinical trials+3 | Dr. Steven Heymsfield | bimagrumabsemaglutide+1 | — | bimagrumabsemaglutide+5 | — | 38m 42s | ||
| 3/13/26 | menopausebody composition+3 | Dr. Alyssa Olenick | — | — | menopausemuscle+4 | — | 49m 39s | ||
| 3/6/26 | creatinesupplementation+3 | Dr. Lauren | — | — | creatinesupplementation+5 | — | 35m 06s | ||
| 2/23/26 | sleep hygieneCBT-I+5 | — | — | — | sleep advicemelatonin+7 | — | 48m 33s | ||
| 2/12/26 | fertilityPCOS+4 | Dr. Lucky Sekhon | The Lucky Egg | — | GLP-1fertility+6 | — | 54m 19s | ||
| 1/30/26 | excellencemotivation+3 | Brad Stulberg | — | — | excellencebiohacking+4 | — | 45m 13s | ||
| 1/20/26 | GLP-1Wegovy+4 | Dr. Karl | WegovyZepbound+1 | — | WegovyGLP-1+5 | — | 25m 23s | ||
| 1/12/26 | Breaking Down the New Food Pyramid (Great or Confusing) | The new U.S. Dietary Guidelines just dropped, and the internet is freaking out over the updated food pyramid. In this episode, we break down what the guidelines actually say, who they’re really written for (hint: mostly policymakers, not everyday people), and why the pyramid graphic can be more confusing than helpful. We also dig into the biggest inconsistencies like the push for more protein and “natural fats,” the mixed messaging on saturated fat, and the messy “processed foods” debate without a clear definition. Bottom line: there’s some reasonable advice here, but a lot of the hype is performative, and the real impact depends on how these guidelines get translated into actual policy like school lunches and federal programs. | — | ||||||
| 1/7/26 | Cortisol Myths vs Reality: What Your Adrenals Actually Do | We hear “high cortisol” blamed for everything, but your adrenal glands are supposed to make cortisol in a daily rhythm that helps you wake up, fuel exercise, and handle illness. In this episode, we break down what cortisol actually does, how real adrenal disorders like Cushing’s are diagnosed, and why random at home cortisol tests and “adrenal fatigue” claims are usually misleading. | — | ||||||
| 12/5/25 | GLP-1 Side Effects Deep Dive: Slimmer's Paralysis, Bladder Spasms, & Reactive Hypoglycemia. | In this episode, Dr. Spencer and Dr. Karl break down some of the strangest and most misunderstood GLP-1 side effects, from slimmer’s paralysis and foot drop to bladder spasms and post-bariatric reactive hypoglycemia. They walk through real patient cases, why these issues happen, and what clinicians and patients can do to spot them early and manage them safely. | — | ||||||
| 11/19/25 | GLP-1s and Breast Milk: What the New Research Actually Found | In this episode, we sit down with leading lactation researcher Dr. Kaytlin Krutsch break down the first real human data on GLP-1 medications in breast milk. She explains what the studies found, what women should consider before starting these medications postpartum, and why the actual risk may be far lower than most people think. | — | ||||||
| 11/12/25 | How to Build Healthy Routines That Actually Stick | In this episode, Dr. Spencer and Dr. Karl talk with Dr. Karin Nordin, behavioral change specialist and founder of Body Brain Alliance, about why most advice on motivation, discipline, and habits gets it wrong. They break down the science of behavior change, exploring how identity, self-efficacy, and “future self thinking” can help people finally follow through on healthy routines that last. | — | ||||||
| 11/3/25 | The Truth About Testosterone Therapy in Women (with Dr. Susan Davis) | In this episode, Dr. Spencer Nadolsky and Dr. Karl engage with Dr. Susan Davis, a leading endocrinologist and researcher in testosterone therapy for women. They explore the complexities of sexual dysfunction, the role of testosterone in women's health, and the nuances of diagnosing and treating low sexual desire. The conversation delves into the importance of understanding psychosocial factors, the limitations of current testosterone testing, and the appropriate dosing and administration of testosterone therapy. Dr. Davis emphasizes the need for evidence-based practices and the importance of individualized patient care in managing women's sexual health. | — | ||||||
| 10/23/25 | From Injections to Pills: Breaking Down the New Oral GLP-1 Data | Dr. Spencer and Dr. Karl sit down with Dr. Sean Wharton, lead author on the OASIS-4 and ATTAIN-1 trials, to unpack the groundbreaking data behind the new oral GLP-1 medications. They discuss how oral semaglutide and orforglipron compare to injectables, what makes these molecules unique, and why 2026 could be the year obesity care changes forever. | — | ||||||
Showing 25 of 158
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Similar Audience Demographics
Podcasts that attract a similar listener profile
On The Pen GLP-1 News
Dave Knapp GLP-1 Industry Insider
Fat Science
Dr Emily Cooper
The Obesity Guide with Matthea Rentea MD
Matthea Rentea MD
GLP-1 Hub: Support, Community, and Weight Loss
Ana Reisdorf, MS, RD
Barbell Medicine Podcast
Barbell Medicine
The Plus SideZ: A GLP-1 Guide to Metabolic Health
Kim Carlos
The GLP-1 Podcast Show
Wisenetix
Chart history for Docs Who Lift
Peaked at #29 in Netherlands, currently #29 in Netherlands.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| Netherlands | — | #29 | #29 | — |
| IS | — | #31 | #31 | — |
| CL | — | #42 | #42 | — |
| KE | — | #49 | #49 | — |
| MY | — | #59 | #59 | — |
| United States | — | #72 | #72 | — |
| Ireland | — | #80 | #80 | — |
| PH | — | #94 | #94 | — |
| PL | — | #98 | #98 | — |
| RO | — | #114 | #114 | — |
| Sweden | — | #118 | #118 | — |
| HK | — | #118 | #118 | — |
| GR | — | #153 | #153 | — |
| Australia | — | #159 | #159 | — |
| United Kingdom | — | #161 | #161 | — |
| CH | — | #165 | #165 | — |
| New Zealand | — | #195 | #195 | — |
Chart Positions
17 placements across 17 markets.
Chart Positions
17 placements across 17 markets.